Schaefer F V, Floyd M, Say B
University of Oklahoma College of Medicine-Tulsa.
J Okla State Med Assoc. 1992 May;85(5):223-6.
As recombinant DNA diagnoses of various inherited diseases become a standard medical procedure, the practicing physician will be required to identify families at risk and counsel them (or refer them) appropriately. In many families the risk may not be immediately obvious or a reliable risk figure may appear to be unattainable. In the case presented, the patient had an apparent 50% risk for Huntington disease and all the immediate affected relatives were deceased. This relatively common scenario would generally prevent recombinant DNA diagnostic procedures from arriving at a more accurate risk estimate. Nevertheless, by recombinant DNA analysis, a risk for Huntington disease of less than 1% was obtained. Several key aspects of genetic analysis were required including extensive family histories, identification of informative markers, ordering the markers around the disease gene and appropriate statistical analyses. These discussions illustrate the power of recombinant DNA techniques to detect genetic disorders and demonstrate why they will be of increasing importance to the practicing physician.
随着对各种遗传性疾病的重组DNA诊断成为一种标准医疗程序,执业医师将需要识别有风险的家庭并给予适当的咨询(或转诊)。在许多家庭中,风险可能不会立即显现,或者似乎无法获得可靠的风险数值。在所述案例中,患者患亨廷顿病的风险看似为50%,而所有直接受影响的亲属均已去世。这种相对常见的情况通常会妨碍重组DNA诊断程序得出更准确的风险估计。然而,通过重组DNA分析,得出患亨廷顿病的风险低于1%。这需要进行遗传分析的几个关键方面,包括广泛的家族病史、识别信息性标记、在疾病基因周围排列标记以及进行适当的统计分析。这些讨论说明了重组DNA技术在检测遗传疾病方面的作用,并证明了为什么它们对执业医师将变得越来越重要。